Physician profile
George Gorich
NPI 1730125618
$11,936.42
in general payments reported to CMS, 2019-2025
53 companies · $2,831 in 2025
The $2,831 reported for 2025 was more than what 98% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $588 · 2020: $233 · 2021: $789 · 2022: $1,450 · 2023: $2,502 · 2024: $3,543 · 2025: $2,831.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,774 · Education: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,773.68 |
| Education | $102.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,532.59 | 2023-2025 | |
| Novo Nordisk INC | $915.21 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $880.41 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Otsuka America Pharmaceutical, INC. | $839.06 | 2021-2025 | Rexulti, Nuedexta |
| Pfizer INC. | $781.07 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $533.88 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $519.41 | 2021-2025 | |
| Collegium Pharmaceutical, INC. | $437.64 | 2019-2025 | Belbuca, Nucynta |
| Astrazeneca Pharmaceuticals Lp | $381.03 | 2022-2024 | Breztri, Airsupra, Lokelma |
| Braeburn INC. | $340.87 | 2024-2025 | Brixadi |
| Indivior INC. | $338.55 | 2021-2025 | Sublocade |
| Avanir Pharmaceuticals, INC. | $280.03 | 2019-2022 | |
| Mylan Specialty L.P. | $278.40 | 2023-2024 | Yupelri, Yupelri |
| Alkermes, INC. | $268.26 | 2019-2025 | Vivitrol, Vivitrol |
| Lundbeck LLC | $253.67 | 2023-2025 | Rexulti |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Gorich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.